Notes / Company

Aspira Pathlab & Diagnostics Ltd.

ASPIRA BSE 540788 ISIN INE500C01017 Diagnostics

Fundamentals

Market cap: ₹135 cr
P/E: 56.31×
ROE: 16.62%
Debt / equity: 0.10
52-week range: 49.00 — 135.88

Research on Tijori Finance

Company snapshot

Aspira Pathlab & Diagnostics Ltd.

Diagnostic Chains

₹111 cr

P/E 46.19×

Latest quarter · Jun 2025

Sales₹5 cr

Net profit₹0 cr

Op. margin+15.6%

EPS₹0.41

Strength & growth

Debt / equity0.10×

Current ratio2.26×

Sales CAGR+47.4%

The timeline — 1 note on Aspira Pathlab & Diagnostics Ltd.

July 2026

25 Jul 26 · 3:03 PM IST Brief

Brief · Micro cap

Aspira Pathlab loses executive director months after appointment

Vaibhav Odhekar resigns for 'personal reasons' effective July 25, 2026, raising management continuity questions at the **₹135 cr** diagnostics firm.

Verify on exchange BSE filings for ASPIRA NSE filings for ASPIRA Tijori Finance company page